burger-menu close-panel
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Or Choose Category
Stem Cells & Therapies
On Women's Health
Chemical Abortion
Peer Reviewed
Fetal Development
Press Release
End of Life
Fetal Tissue, Stem Cells & Bioethics
Abortion
Maternal & Public Health
Research
Life & the Law
General
Trending Research
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

fda

fda

Or Choose Category
Stem Cells & Therapies
On Women's Health
Chemical Abortion
Peer Reviewed
Fetal Development
Press Release
End of Life
Fetal Tissue, Stem Cells & Bioethics
Abortion
Maternal & Public Health
Research
Life & the Law
General
Trending Research
6 results

Filter Results By

Filter Applied. Clear All

Latest Posts

December 7, 2023 Understanding Women’s Communication with Their Providers During Medication Abortion and Abortion Pill Reversal: An Exploratory Analysis Understanding Women’s Communication with Their Providers During Medication Abortion and Abortion Pill Reversal: An Exploratory Analysis December 7, 2023 Medication Abortion and Abortion Pill Reversal: An Exploratory Analysis on the Influence of Others in Women’s Decision-Making Medication Abortion and Abortion Pill Reversal: An Exploratory Analysis on the Influence of Others in Women’s Decision-Making November 20, 2023 Hoja Informativa: Riesgos y Complicaciones del Aborto Químico Hoja Informativa: Riesgos y Complicaciones del Aborto Químico
Research Type
By State
See All
By Author
See All
Reset All Filters

Did You Know ?

Did You Know ?

In the fourth week, the embryonic heart starts beating. The neural tube, which becomes the brain and spinal cord, forms. At this point, a woman has likely only been aware of her pregnancy for one week.

Did You Know ?

In the seventh week after conception, networks of neurons produce brain waves that have been recorded as early as 6 ½ weeks after conception. The embryo spontaneously moves his arms, hands, and legs, and may even hiccup. The embryo’s heart now has all four chambers.

Did You Know ?

By the seventeenth and eighteenth week after gestation, the fetus shows a clear response to pain in multiple studies, and at least one brain pathway is mature enough to create a perception of pain. The fetus also practices breathing, crying, and breastfeeding in the womb. The fetal heart has beat over 20 million times and circulates about 55 quarts of blood per day.

Did You Know ?

In the eighth month of pregnancy the fetal brain is ready to learn! At 32 weeks after conception, neurons are creating 40,000 new connections, called synapses, every second! With repeated exposures, the fetus can learn flavors, nursery rhymes, songs, and even words that she will recognize after birth!

6 results
fda

Chemical Abortion: FDA Ignores ‘Inconvenient’ Science and Data Confirming Public Health Threat

The U.S. Food and Drug Administration (FDA) today announced plans to irresponsibly erode longstanding patient safeguards on the abortion pill, despite major U.S. and international research confirming that chemical abortion has led to a surge in emergency room visits and higher rates of complications.

charlotte-lozier-institute Charlotte Lozier Institute
December 16, 2021
ClosePlease loginn
fda

Public Health Threat: Chemical Abortion Leads to Significantly Higher Rate of ER Visits

As the Food and Drug Administration (FDA) works toward a December 16 decision on chemical abortion safeguards, a groundbreaking new study from Charlotte Lozier Institute (CLI) shows that increased access to abortion pills creates a significant public health risk.

charlotte-lozier-institute Charlotte Lozier Institute
November 16, 2021
ClosePlease loginn
featured-image
fda

FDA’s Race to Defend Women From Dangerous Drugs

Abortion advocates—seeking to exploit the COVID-19 crisis to advance unfettered access to abortion-inducing drugs—found a friend in federal court.  In mid-July, Judge Theodore D. Chuang issued a preliminary injunction prohibiting the Food and Drug Administration (FDA) from enforcing certain health and safety practices that abortion providers are required to follow when prescribing the only FDA-approved abortion drug regimen.

Mary E. Harned, J.D.
August 19, 2020
ClosePlease loginn
featured-image
fda

News Release: Abortion Activist Sues FDA over Regulation of Dangerous Drugs 

Today Charlotte Lozier Institute released the following response to a lawsuit seeking to stop U.S. Food and Drug Administration enforcement of the regulation of dangerous abortion drugs shipped into the United States from overseas.

charlotte-lozier-institute Charlotte Lozier Institute
September 9, 2019
ClosePlease loginn
featured-image
fda

Bicameral Congressional Letter Demands Transparency from FDA

Yesterday 75 members of Congress, led by Rep. Chris Smith of New Jersey and Sen. James Lankford of Oklahoma, sent

Charles A. “Chuck” Donovan
April 26, 2016
ClosePlease loginn
fda

Medication Abortion: FDA Guidelines and Personal Experience

Last week, the Food and Drug Administration (FDA) changed the regulations for RU-486, the “abortion pill,” allowing its use up

Genevieve Plaster, M.A.
April 7, 2016
ClosePlease loginn

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image